Donepezil Plus Solifenacin (CPC-201) Treatment for Alzheimer’s Disease

Neurobiology of Alzheimer’s Disease: Integrated Molecular, Physiological, Anatomical, Biomarker, and Cognitive Dimensions

(2015) Joel Raskin et al.   Current Alzheimer Research

Pharmacokinetic and pharmacodynamic evaluation of donepezil for the treatment of Alzheimer's disease

(2014) David Prvulovic et al.   Expert Opinion on Drug Metabolism & Toxicology

Effectiveness of Cholinesterase Inhibitors and Memantine for Treating Dementia: Evidence Review for a Clinical Practice Guideline

(2013) Parminder Raina et al.   ANNALS OF INTERNAL MEDICINE

Pharmacodynamic, Pharmacokinetic and Pharmacogenetic Aspects of Drugs Used in the Treatment of Alzheimer’s Disease

(2013) Muriel Noetzli et al.   CLINICAL PHARMACOKINETICS

Concentration of Donepezil to the Cognitive Response in Alzheimer Disease

(2013) Yuan-Han Yang et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Guy M. McKhann et al.   Alzheimers & Dementia

Rosiglitazone Does Not Improve Cognition or Global Function when Used as Adjunctive Therapy to AChE Inhibitors in Mild-to-Moderate Alzheimers Disease: Two Phase 3 Studies

(2011) C. Harrington et al.   Current Alzheimer Research

Antimuscarinic Drugs: Review of the Cognitive Impact When Used to Treat Overactive Bladder in Elderly Patients

(2011) Dustin Pagoria et al.   Current Urology Reports

Effectiveness and tolerability of high-dose (23 mg/d) versus standard-dose (10 mg/d) donepezil in moderate to severe Alzheimer's disease: A 24-week, randomized, double-blind study

(2010) Martin R. Farlow et al.   CLINICAL THERAPEUTICS

Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe

(2010) H. H. Feldman et al.   NEUROLOGY

Defining Treatment Response to Donepezil in Alzheimer’s Disease

(2009) Alistair Burns et al.   DRUGS & AGING